Skip to Main Content

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Centrexion Therapeutics hired Andrew Partridge as executive vice president, chief commercial officer. Previously, he worked Vertex Pharmaceuticals (VRTX), where he was senior vice president, regional head of North America commercial.


Bayer (BAYRY) named Sebastian Guth as pharmaceuticals president for its Americas region;

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Hmmm, would “Dance Biopharm Holdings hired Anne Whitaker as chief executive officer” mean a former Valeant exec has found a new home?
    And, for full disclosure, any relationship, other than the spelling?
    “Merus named Peter B. Silverman as executive vice president, general counsel”

Comments are closed.